ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cytocom Receives IND for CYTO-205 Trial for COVID-19
March 23, 2021Cytocom announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of ... -
Cytocom Gets FDA Clearance for Phase II Trial of COVID Immune Therapy
March 17, 2021Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of SARS-CoV-2. -
Cytocom submits IND application to conduct Phase II Covid-19 drug trial
February 19, 2021Cytocom has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA), with updated protocols, to begin a Phase II clinical trial of CYTO-205 for treating Covid-19.
Pharma Sources Insight January 2025
